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LKB1 is a ‘master’ protein kinase implicated in the regulation of
metabolism, cell proliferation, cell polarity and tumorigenesis.
However, the long-term role of LKB1 in hepatic function is
unknown. In the present study, it is shown that hepatic LKB1
plays a key role in liver cellular architecture and metabolism.
We report that liver-specific deletion of LKB1 in mice leads to
defective canaliculi and bile duct formation, causing impaired
bile acid clearance and subsequent accumulation of bile acids
in serum and liver. Concomitant with this, it was found that
the majority of BSEP (bile salt export pump) was retained
in intracellular pools rather than localized to the canalicular
membrane in hepatocytes from LLKB1KO (liver-specific Lkb1-
knockout) mice. Together, these changes resulted in toxic
accumulation of bile salts, reduced liver function and failure to
thrive. Additionally, circulating LDL (low-density lipoprotein)-
cholesterol and non-esterified cholesterol levels were increased
in LLKB1KO mice with an associated alteration in red blood
cell morphology and development of hyperbilirubinaemia. These
results indicate that LKB1 plays a critical role in bile acid
homoeostasis and that lack of LKB1 in the liver results in
cholestasis. These findings indicate a novel key role for LKB1 in
the development of hepatic morphology and membrane targeting
of canalicular proteins.
Key words: AMP-activated protein kinase (AMPK), ATP-bind-
ing-cassette subfamily B, member 11 (ABCB11), bile salt export
pump (BSEP), cholestasis, hyperbilirubinaemia, polarity.
INTRODUCTION
LKB1 encodes an evolutionarily conserved serine/threonine
protein kinase that was originally identified as a tumour
suppressor, as inactivating mutations in LKB1 in humans cause
Peutz–Jeghers syndrome [1,2]. More recently, LKB1 has been
shown to act upstream of AMPK (AMP-activated protein kinase)
[3–5] and 12 AMPK-related kinases [6]. LKB1 phosphorylates a
conserved threonine residue within the T-loop of these kinases,
which is essential for their activation [7]. Activation of AMPK by
LKB1 under conditions of energy depletion results in the down-
regulation of energy-consuming pathways and the up-regulation
of ATP-producing pathways. Much less is understood regarding
the roles of the AMPK-related kinases, although there is evidence
to suggest that the MARK [MAP (microtubule-associated
protein)-regulating kinase/microtubule affinity-regulating kinase]
[8] and BRSK (brain-specific kinase) [9,10] subfamilies play
roles in determining cell polarity. Information concerning the
physiological function of the remaining AMPK-related kinases
is extremely limited [11].
Germline deletion of LKB1 leads to an embryonic-lethal
phenotype with mice dying from a variety of vascular and
placental defects, demonstrating a key developmental role [12].
Tissue-specific deletion of LKB1 has been investigated in several
mouse models [13–15] with phenotypes affecting various aspects
of cell morphology and organ dysfunction. Taken together these
findings suggest that LKB1 plays a key role in integrating cell and
tissue morphology with metabolic function.
The liver has many metabolic functions including bile
production together with key regulatory roles in glucose, lipid
and xenobiotic metabolism. Bile is the main vehicle by which
the body disposes of excess cholesterol by conversion into bile
acids and the route used for the excretion of waste products
such as bilirubin, a breakdown product of haem. Because high
levels of bile acids can cause tissue damage due to their strong
detergent properties, their concentrations are tightly regulated by
transcriptional control of many genes in a complex feedback
mechanism involving bile acid activation of FXR (farnesoid X
receptor) (reviewed in [16]). Following their synthesis in the liver,
bile acids are secreted into the bile, stored in the gall bladder and
released postprandially into the small intestine, where they play
a critical role in the absorption of fat and fat-soluble nutrients.
The majority of the bile acids are then returned to the liver
via the portal circulation through ASBT (apical sodium-dependent
bile acid transporter) in the epithelial cells of the small intestine.
Completion of the enterohepatic circulation occurs when the bile
acids are returned to the liver mainly by transport via NTCP
(sodium–taurochloate co-transporting protein). A major feature
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of hepatocytes is their marked anatomical polarity, which plays
an essential role in their function. For example, the polar nature
of hepatocytes allows the efficient vectorial transport of bile acids
from the portal blood into the hepatocytes via NTCP and then
into the intrahepatic biliary system via BSEP (bile salt export
pump). BSEP is a member of the ABC (ATP-binding-cassette)
transporter family and is classified as ABCB11 (ABC subfamily
B, member 11). BSEP is regulated both transcriptionally and post-
translationally, and mediates canalicular bile formation [17]. In
the present study, we show that hepatic LKB1 plays a key role
in liver cellular architecture and metabolism. Absence of hepatic
LKB1 results in mis-localization of BSEP, bile duct paucity and
impairment of postnatal biliary tree formation. LLKB1KO (liver-
specific Lkb1-knockout) mice also display impaired bile acid and
lipid metabolism, and die within 4 weeks of birth.
MATERIALS AND METHODS
Generation of mice lacking hepatic LKB1
Production of mice harbouring Lkb1-floxed alleles has been
described previously [14]. These mice were crossed with
B6.Cg-Tg (Alb-Cre) 21 Mgn/J transgenic mice harbouring Cre-
recombinase under the albumin promoter (Jackson Laboratories).
All animal studies were performed in accordance with the
Animal Scientific Procedures Act. Animals were killed by cervical
dislocation, and organs were rapidly removed and frozen in liquid
nitrogen.
Western blotting
Proteins were resolved on 4–12% gradient gels (Novex,
Invitrogen), transferred on to PVDF membranes and probed with
antibodies as described in the text. Antibodies were detected by
ECL (enhanced chemiluminescence) (West Dura kit; Pierce).
Antibodies
The sheep anti-LKB1 antibody, raised against residues 24–39
of human LKB1, was generously provided by Professor Dario
Alessi (Division of Signal Transduction Therapy, University of
Dundee, Dundee, Scotland, U.K.). The mouse monoclonal anti-
LKB1 antibody (Ley37D/G6) and goat anti-radixin antibody were
from Santa Cruz Biotechnology. Rabbit anti-LKB1 antiserum
[18], rabbit pan-AMPKβ antibody and sheep anti-AMPKα1 and
-AMPKα2 antibodies [19] were as described previously. The
anti-BSEP and -NTCP antibodies were generously provided by
Professor Bruno Stieger (Division of Clinical Pharmacology and
Toxicology, University Hospital, Zurich, Switzerland) [20,21].
The goat anti-(mouse osteopontin) antibody was from R&D
Systems, and the anti-CK19 antibody was from Dako (IS615).
Haemocrit measurement
Blood was collected in haemocrit tubes and centrifuged at 3000 g.
Packed red cell volume was measured as a ratio of the total blood
sample volume.
Immune complex kinase assays
LKB1 or AMPK complexes were immunoprecipitated from
soluble liver lysates using antibodies bound to either Protein
A– or Protein G–Sepharose. After extensive washing, kinase
activity present in the immune complexes was determined as
described previously [3]. AMPK activity was measured by [32P]Pi
incorporation into the SAMS peptide (HMRSAMSGLHLVKRR)
[22]. LKB1 activity was measured by activation of bacterially
expressed AMPK complex (α1, β1 and γ 1), which was
subsequently assayed using the SAMS peptide.
Osmotic fragility test
The osmotic fragility test was performed according to the method
described by Foller et al. [23].
Transmission electron microscopy
After glutaraldehyde fixation and processing, samples were em-
bedded in araldite. Semi-thin sections of 0.5–1 μm were stained
with Toluidine Blue in borax. Ultra-thin sections were stained in
uranyl acetate followed by Reynold’s lead citrate.
Histology and immunohistochemistry
Tissue was fixed in formalin/saline and processed in paraffin
wax. Routine sections were stained with haematoxylin and
eosin. Immunohistochemical staining was carried out on the
Dako Autostainer Plus using a diaminobenzidine-based system
to identify antibody binding.
Immunofluorescence microscopy
Livers were fixed in paraformaldehyde, and frozen sections were
used for staining. Appropriate Alexa Fluor® 488-conjugated
secondary antibodies were used, and DAPI (4′,6-diamidino-2-
phenylindole) was used as a nuclear stain.
Liver function tests and metabolite measurements
Serum levels of albumin, ALP (alkaline phosphatase),
total cholesterol, LDL (low-density lipoprotein)-cholesterol
and HDL (high-density lipoprotein)-cholesterol, bilirubin and
triacylglycerols (triglycerides) were determined by the Mouse
Biochemistry Laboratories, Cambridge, U.K. Assays were
measured colorimetrically on a Dade Behring RXL autoanalyser.
Esterified and non-esterified cholesterol measurements were
made using an Amplex Red Cholesterol kit (Molecular
Probes). Bile acids were measured using a TBA bile acid kit
(Sentinel Diagnostics). Bile acids were extracted from livers by
homogenization ten times in 70% (v/v) ethanol.
Isolation of hepatocytes
Hepatocytes were isolated by collagenase perfusion of livers from
14–18-day-old anaesthetized mice. After isolation, cells were
seeded in collagen-coated dishes in Medium 199 with Earle’s
salts and L-glutamine (Gibco) supplemented with UltroserG (Pall
Life Sciences), 1% (w/v) albumin, 100 nM insulin, 100 nM
T3 (tri-iodothyronine) and 100 nM dexamethasone. After cell
attachment, the hepatocytes were cultured for 16–18 h in the
absence of T3, albumin and UltroserG and in the presence of
1 nM insulin
Bile acid uptake assay
The bile acid uptake assay was carried out as described previously
[24].
c© The Authors Journal compilation c© 2011 Biochemical Society© 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
2
Role of LKB1 in bile acid transport and canalicular membrane integrity 51
Table 1 Sequences of the oligonucleotide primers used for qRT-PCR
Srebp, sterol-regulatory-element-binding protein; HmgCoAR, 3-hydroxy-3-methylglutaryl-CoA
reductase.
mRNA Forward (5′→3′) Reverse (5′→-3′)
Abcg5 TGGGTCCCAAGGAGTATGC GCTCCAAGACTTCACACAGTG
Abcg8 AGTGGTCAGTCCAACACTCTG GAGACCTCCAGGGTATCTTGAA
Bsep GGGAGCAGTGGGTGTGGTAAAAG TCCTGGGAGACAATCCCAATGTT
Cypb TGGAGAGCACCAAGACAGACA TGCCGGAGTCGACAATGAT
Cyp7a1 AGCAACTAAACAACCTGCCAGTACTA GTCCGGATATTCAAGGATGCA
Fxr GGCAGAATCTGGATTTGGAATCG GCTGAACTTGAGGAAACGGG
HmgCoAR GATTCTGGCAGTCAGTGGGAA GTTGTAGCCGCCTATGCTCC
Mrp2 ATGAAGTGACAGAGGGCGGT TGCAGCCTGTGTGCGATAG
Mrp3 GCAGCAGAACCAAGCATCAAG GACCGCATCCTCACCTGG
Mrp4 GGTTGGAATTGTGGGCAGAA TCGTCCGTGTGGTCATTGAA
Ntcp CTGCCGCCTGGCTTTGGCCA CTGGAGCAGGTGGTCATCAC
Oatp1 TGATACACGCTGGGTCGGTG GCTGCTCCAGGTATTTGGGC
Shp CGATCCTCTTCAACCCAGATG AGGGCTCCAAGACTTCACACA
Srebp1a GTTGATGAGCTGGAGCATGT CTCCCTCCTTACCCTTGGAG
Srebp1c GGAGCCATGGATTGCACATT GCTTCCAGAGAGGAGGCCAG
Srebp2 GCGTTCTGGAGACCATGGA ACAAAGTTGCTCTGAAAACAAATCA
qRT (quantitative real-time)-PCR analysis
RNA was isolated from livers by homogenization in TRIzol®
reagent (Invitrogen), according to the manufacturer’s instructions,
followed by purification on an RNeasy column (Qiagen). A
total of 2 μg of RNA was used for first-strand cDNA synthesis
using Superscript II (Invitrogen), according to the manufacturer’s
instructions, and qRT-PCR was performed with SensiMix Plus
SYBR kit (Quantace) using Opticon DNA Engine. All primers
used are shown in Table 1. All values are shown relative to the
expression of Cypb (cyclophilin b).
Hepatic glucose output measurement
At 16 h after isolation, hepatocytes were transferred into glucose-
free DMEM (Dulbecco’s modified Eagle’s medium) (Sigma)
containing 2 mM sodium pyruvate and 20 mM lactate. Aliquots
of medium were removed for glucose measurement at the stated
times using a glucose oxidase kit (Thermo Scientific), according
to the manufacturer’s instructions.
Statistical analysis
All results are presented as means+−S.E.M. In order to determine
statistical significance, an unpaired two-tailed Student’s t test was
performed for the analysis of two groups, whereas data involving
more than two groups were assessed using ANOVA. Statistically
significant differences from wild-type were considered for P
values <0.05.
RESULTS
Generation of LLKB1KO mice
We crossed mice expressing Cre-recombinase under the control
of the albumin promoter [25] with mice harbouring floxed alleles
of Lkb1 [14] to generate Cre+/− Lkb1fl/fl animals lacking LKB1
expression in the liver. PCR for the recombination event in a
range of tissues demonstrated deletion of Lkb1 specifically in the
liver (Figure 1A). LKB1 protein expression was not detectable
in liver extracts from 15-day-old LLKB1KO mice (Figure 1B).
Hepatic LKB1 activity was barely detectable following birth
and reached minimal levels by postnatal day 15 (Figure 1C),
confirming functional deletion of LKB1 by 15 days of age. LKB1
protein expression and activity were also reduced in livers from
Lkb1fl/fl mice (Figures 1B and 1C). These findings are consistent
with a previous study [14] and arise due to the nature of the
targeting event leading to a hypomorphic effect in several tissues.
AMPK activity assayed in immune complexes isolated from liver
extracts from LLKB1KO mice was drastically reduced relative
to wild-type activity (Figure 1D). At 15 days, the activity of
AMPKα1-containing complexes was reduced by approx. 90%
and AMPKα2 activity by >95% in liver from LLKB1KO
mice compared with the activity in liver extracts from wild-
type mice (Figure 1D). There was also a slight reduction in AMPK
activity in liver extracts isolated from Lkb1fl/fl mice, although
this did not reach statistical significance for AMPKα2 complexes
(Figure 1D). In previous studies, it was reported that deletion
of LKB1 in skeletal muscle [26] or heart [27] resulted in loss of
AMPKα2 activity, but AMPKα1 activity was only partially
reduced or was up-regulated. Given the results obtained in the
present study in liver, the contribution of LKB1 to activation
of AMPKα1 appears to vary depending on the tissue type.
LLKB1KO mice were noticeably smaller than either Lkb1fl/fl or
wild-type mice and had significantly lower body weight from
4 days of age, and rapidly began to lose weight from around
15 days of age (Figure 1E). In contrast, the weight of livers isolated
from LLKB1KO mice aged 15 days was significantly increased
compared with wild-type mice (0.39+−0.045 g compared with
0.28+−0.008 g respectively, n = 9). This hepatomegaly resulted in
a significant increase in the liver/body weight ratio (Figure 1F). By
12 days of age, LLKB1KO mice started to die and no LLKB1KO
mice survived beyond 30 days of age (results not shown). We have
been unable to find any obvious metabolic or growth phenotype
for Lkb1fl/fl, even though there is a significant decrease in LKB1
activity in a number of tissues in these mice compared with wild-
type animals. One notable exception is that the male Lkb1fl/fl mice
are infertile due to a defect in spermatogenesis, which has been
described in a previous study [28].
LKB1 deletion leads to disrupted canalicular membranes and
defective bile duct formation
In order to explore the increased mortality of the LLKB1KO
mice, we undertook histological examination of the liver. No gross
morphological changes were apparent and the LLKB1KO mouse
had a patent common bile duct. In livers from LLKB1KO
mice as young as 4 days old, there were increased bile ductular
profiles, but no well-formed ducts around the portal tracts. This
observation became more apparent with increasing age, as shown
in Figure 2(A) for liver isolated from a 15-day-old animal.
Identification of normal bile ducts was difficult in tissue from
LLKB1KO mice 15 days old or older, whereas bile ducts were
clearly visible in livers from wild-type animals at an equivalent
age (Figures 2A–2C). Immunostaining for either osteopontin
(Figure 2B), a protein excreted by biliary epithelial cells, or
CK19 (Figure 2C), a biliary cytokeratin, showed staining in
morphologically normal bile ducts in wild-type liver (indicated
by * in Figure 2). Although there was staining in liver from
LLKB1KO mice, this was associated with the increased bile
ductular profiles (indicated by an arrow in Figure 2) and confirmed
the lack of morphologically normal bile ducts. The expression
of radixin, a protein usually located at hepatic canalicular
membranes, was clearly reduced in livers from LLKB1KO mice
(Figure 2D). In contrast, vascular staining in LLKB1KO
mice appeared normal (indicated by ‘v’ in Figure 2, and results
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Figure 1 Liver-specific deletion of Lkb1
(A) DNA from tissues of 15-day-old mice and recombination of the floxed Lkb1 allele detected by PCR. The recombination product is indicated by an arrow. IL-2 (interleukin-2) was used as an
internal control. (B) LKB1 immune complexes from liver homogenates were immunoblotted for LKB1 in wild-type (Wt), Lkbfl/fl and LLKB1KO mice. (C) LKB1 activity measured in duplicate immune
complexes from liver homogenates (n = 3). (D) AMPK activity was measured in AMPKα1- or α2-specific immune complexes isolated from liver homogenates of 15-day-old mice (n = 5). Results
are expressed as units/mg of total protein, where 1 unit = 1 nmol of 32PO4 incorporated into the SAMS peptide/min. (E) Body weights of wild-type or LLKB1KO mice are shown at the indicated
days after birth (n = 9–11). (F). Liver weight/body weight ratio. Results are means+−S.E.M. Statistically significant differences from wild-type are shown by * (P < 0.05), ** (P < 0.01) and ***
(P < 0.001).
not shown). Transmission electron microscopy revealed ordered
open canalicular channels (c) with well-defined microvilli (mv)
in sections of livers from wild-type mice (Figure 3A). In livers
from LLKB1KO mice, abnormal canaliculi were apparent with
microvilli often appearing ‘glued’ together from as young as
6 days old. An example of a liver from a 15-day-old mouse
is shown in Figure 3(B). In order to determine liver function,
serum levels of several liver markers were measured. By 15 days
of age, serum levels of ALP, ALT (alanine transaminase) and
AST (aspartate transaminase) were all significantly increased
in LLKB1KO mice (Figure 3C), whereas albumin levels were
lower compared with wild-type (Figure 3D). By 15–20 days, there
were patchy areas of necrosis within livers from LLKB1KO mice
(Figure 3E). No significant differences were detected in Lkb1fl/fl
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Figure 2 Altered liver architecture in livers from LLKB1KO mice
Livers from 15-day-old wild-type (Wt) and LLKB1KO mice were stained with haematoxylin and eosin (H&E) (A), and immunostained with osteopontin (OPN) (B), CK19 (C) or radixin (D). Arrows
indicate increased bile ductular profiles and no morphologically normal open bile ducts in LLKB1KO mice. Normal bile ducts are indicated with * and blood vessels are labelled ‘v’ in each case. An
example representative of at least three livers is shown.
mice compared with wild-type mice (Figure 3, and results not
shown).
LLKB1KO mice display marked changes in cholesterol and bile
acid metabolism
Given the abnormal liver architecture and in particular the lack
of normal bile ductule formation in the LLKB1KO mice, we
investigated cholesterol and bile acid metabolism in these animals.
Serum cholesterol levels were significantly elevated in LLKB1KO
mice by 8 days of age and continued to rise with increasing
age (Figure 4A). In wild-type mice, only 15% of circulating
cholesterol was non-esterified, whereas in LLKB1KO mice more
than 50% was non-esterified (Figure 4B). Measured at 15 days
of age, total cholesterol was significantly higher and LDL-
cholesterol was 10-fold higher in LLKB1KO mice compared
with wild-type or Lkb1fl/fl mice, whereas HDL-cholesterol and
triacyglycerol levels were not significantly changed (Figure 4C).
There was a significant increase in the concentration of serum
bile acids by 4 days of age in LLKB1KO mice relative to
wild-type mice (Figure 4D). The increase in serum bile acids
preceded the elevation in cholesterol levels (compare Figures 4A
and 4D). Levels of bile acids in the livers of LLKB1KO mice
were very high compared with wild-type, albeit with widely
varying levels detected in individual mice (Figure 4E). The rate of
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Figure 3 Altered canalicular morphology and liver function in LLKB1KO mice
Transmission electron micrographs of livers from 15-day-old wild-type (Wt) (A) and LLKB1KO (B) mice showing the canalicular membranes. The canalicular channel is labelled ‘c’, microvilli are
labelled ‘mv’ and tight junctions are labelled ‘tj’. A representative example of at least three livers is shown. (C) Serum levels of ALP, ALT and AST, and (D) albumin from 15-day-old wild-type (Wt)
and LLKB1KO mice. Results are means+−S.E.M. from n = 5 mice per genotype. Statistically significant differences from wild-type values are shown by * (P < 0.05) and ** (P < 0.01). (E) Toluene
Blue-stained liver section from an 18-day-old LLKB1KO mouse showing ‘patchy’ necrosis. This is a representative image of three livers examined.
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Figure 4 Lack of hepatic LKB1 disrupts cholesterol and bile acid metabolism
(A) Total serum cholesterol over time (age shown in days) (n = 4–6). (B) Non-esterified (unesterified) cholesterol as a percentage of total serum cholesterol in 15-day-old mice (n = 4–6). (C) Total
cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol (TG) concentrations from serum of 15-day-old mice are shown (n = 7–10). (D) Serum bile acid concentrations ([BA]) over time
(age in days) (n = 4–6). (E) Bile acids measured in liver extracts from wild-type (Wt) and LLKB1KO mice with the mean value shown by a bar (n = 5–6). (F) [3H]Taurocholate (TC) uptake was
measured in hepatocytes isolated from 15-day-old wild-type or LLKB1KO mice. Uptake is shown relative to wild-type cells. Triplicate measurements of three independent experiments are shown. In
each case, results are means+−S.E.M. Statistically significant differences from wild-type are indicated by * (P < 0.05), ** (P < 0.01) and *** (P < 0.001).
[3H]taurocholate uptake in isolated hepatocytes from LLKB1KO
mice was 5-fold lower than in wild-type cells (Figure 4F), which
could contribute to the elevated levels of serum bile acids. In
order to confirm that the hepatocytes isolated from the LLKB1KO
animals are viable, we measured glucose output in these cells.
Hepatic glucose output was increased in the LLKB1KO cells
compared with wild-type cells under basal conditions (Figure 4G).
This result is consistent with a previous study in which LKB1
was deleted in adult hepatocytes [29], and demonstrates that
the hepatocytes isolated from LLKB1KO mice are metabolically
competent to undergo gluconeogenesis, confirming their viability.
We went on to measure the expression of a number of genes
known to play a role in bile acid transport and homoeostasis
(Figure 5A). There was a significant change in some of the genes
normally regulated by elevated levels of bile acids. The
genes encoding the basolateral transporters OATP1 (organic anion
transporting polypeptide 1) and NTCP were down-regulated,
whereas expression of the gene encoding the basolateral efflux
transporter MRP4 (multi-drug resistance protein 4) was increased.
However, some of the genes expected to be altered by FXR
activation due to high levels of bile acids, such as genes encoding
SHP (small heterodimer partner), CYP7A1 (cytochrome P450,
family 7, subfamily A, polypeptide 1), ABCG5/8 (ABC subfamily
G, member 5/8), MRP3 and BSEP, were not significantly altered.
In addition, we found a decrease in the expression of the gene
encoding MRP2, which encodes a canalicular anion transporter,
whereas other studies have found an increase in expression
in response to elevated bile acids [16]. Despite the increase in
cholesterol levels in the LLKB1KO mice, there were no significant
changes in the expression of a number of genes involved in
cholesterol biosynthesis (Figure 5B), suggesting that there is
no overall up-regulation in cholesterol synthesis. Taken together,
these findings led us to investigate whether the underlying cause of
hepatic bile acid accumulation is a defect in bile acid clearance.
This would be consistent with the lack of open bile ductules
revealed by our histological analyses (Figure 2).
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Figure 5 Expression of genes involved in bile acid and cholesterol homoeostasis
Expression levels of genes in livers of 15-day-old wild-type (Wt) or LLKB1KO mice measured by qRT-PCR for genes involved in bile acid homoeostasis (A) or cholesterol synthesis (B). The results are
shown as relative expression normalized to Cypb, and the ratio of expression in livers from LLKB1KO mice is shown compared with wild-type (Wt) values set as 1 (n = 6). Results are means+−S.E.M.
Statistically significant differences from wild-type are indicated by * (P < 0.05) and ** (P < 0.01). Srebp, sterol-regulatory-element-binding protein; HmgCoAR, 3-hydroxy-3-methylglutaryl-CoA
reductase.
Defective targeting of BSEP in LLKB1KO mice
Since our present findings indicate that increased bile acids in
LLKB1KO mice result from defective clearance, we examined
the expression of BSEP, one of the key components of bile
acid efflux in the liver. BSEP protein expression was unchanged
in livers from LLKB1KO mice, as measured by Western
blotting (results not shown). We therefore extended our analysis
to determine the localization of BSEP protein. In wild-type
mice, as expected, BSEP was localized predominantly at the
canalicular membrane (Figure 6A). In marked contrast, in
liver from LLKB1KO mice, BSEP was found mainly within
the cytoplasm, appearing to be associated with cytoplasmic
vesicles (Figures 6A and 6B). There was no obvious difference
in localization of NTCP, a basolateral membrane protein
(Figure 6C). However, we observed lower NTCP staining in
sections of liver from LLKB1KO mice compared with wild-type
mice.
Loss of hepatic LKB1 leads to abnormal red blood cells and
hyperbilirubinaemia
Examination of red blood cells from LLKB1KO mice at 18 days
of age showed an abnormal morphology, exhibiting a ‘spiky’
appearance (Figure 7A). This altered morphology is similar to that
described for spur cells of patients with severe liver disease [30].
The red blood cells from LLKB1KO mice were also shown to be
more resistant to changes in osmolarity (Figure 7B). The packed
red blood cell volume of LLKB1KO mice was significantly
lower than that in wild-type mice (Figure 7C), implying that the
LLKB1KO mice could be anaemic. Circulating levels of bilirubin,
a product of heam breakdown, were dramatically increased in
LLKB1KO mice, leading to a bright yellow coloration of the
serum (Figure 7D). Bilirubin in serum from either wild-type or
Lkb1fl/fl mice was virtually undetectable, whereas in LLKB1KO
mice the levels were hugely elevated, the majority of which was
conjugated which shows some functionality of the liver in the
older mice.
DISCUSSION
In the present study, we have shown that mice lacking the
expression of LKB1 in the liver have profound abnormalities in
liver architecture and cell morphology that result in severe defects
in bile and cholesterol metabolism. Although LKB1 activity
was reduced in the liver of Lkb1fl/fl mice, there was no hepatic
phenotype, suggesting that there is significant ‘spare capacity’
within the signalling pathway, and that LKB1 is not rate-limiting.
This may be a more general feature of protein kinase signalling
pathways, for example mice expressing 10% of the normal levels
of PDK1 (phosphoinositide-dependent kinase 1) appear normal,
whereas complete deletion results in embryonic lethality [31].
Our present results show that LKB1 is required for the normal
postnatal development of the biliary system, including correct
localization of canalicular membrane proteins and development
of bile ducts. The molecular mechanisms underlying develop-
ment of the biliary tree are poorly understood. A number of
other studies have demonstrated that LKB1 plays a key role in
determining polarity in mammalian cells, as well as in other model
organisms [32]. Activation of LKB1 has been shown to cause
complete polarization of single mammalian epithelial cells [33].
An attractive hypothesis is that LKB1 is required for polarization
of hepatocytes and that disruption of the normal development of
the bile canaliculi in the LLKB1KO mice is a consequence
of a defect in polarity determination. In support of this, we found
that BSEP and radixin were no longer targeted to the canalicular
membrane in the absence of LKB1. The failure to thrive and
loss of weight of LLKB1KO mice may be caused by poor
absorption of nutrients from the intestine due to the inability to
transport bile from the liver via the biliary tree, which is defective
in these animals.
Associated with the marked anatomical abnormalities observed
in LLKB1KO mice we found a number of metabolic defects.
There was a dramatic increase in serum and liver bile acids which
stems from defective clearance of bile acids into the canaliculus
as a direct consequence of mis-localization of BSEP. Previous
studies have shown that bile acids regulate the transcription of
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Figure 6 Cytoplasmic localization of BSEP in LLKB1KO livers
(A) Immunofluorescence staining for BSEP in 15-day-old mice with (B) magnification of the indicated areas shown in (A). (C) Immunostaining of NTCP in livers from 15-day-old mice. An example
representative of at least three livers is shown.
genes encoding proteins involved in bile acid metabolism and
transport. However, in spite of elevated circulating bile acids,
some of the genes known to be transcriptionally controlled
by FXR [34] were not altered in liver from LLKB1KO mice.
We observed a decrease in the expression of the basolateral
transporters Oatp1 and Ntcp, as well as decreased staining
of NTCP in the livers from LLKB1KO mice, which would
explain a decrease in the taurocholate uptake in the isolated
hepatocytes from LLKB1KO animals (Figure 4F). However, the
expected transcriptional up-regulation of those transporters in
the canalicular membrane, for example Bsep, Abcg5/8 and Mrp2,
is not apparent in the livers from LLKB1KO mice. There appears
to be a lack of control of those genes involved in expression of
proteins located to the canalicular membrane. Expression of the
gene encoding CYP7A1, the rate-limiting enzyme in bile acid
synthesis, is not decreased in response to the elevated bile acids
in the livers from LLKB1KO mice. The intestine, as well as
the liver, plays a critical role in bile acid homoeostasis. It has
been shown that, in response to bile acids in the intestine, FXR
stimulates FGF15 (fibroblast growth factor 15) expression in the
intestine which signals via FGFR4 (FGF receptor 4) to bring
about down-regulation of CYP7A1 in the liver. [35]. However,
this route of control is likely to be defective in the LLKB1KO
mice because bile acids are not flowing into the bile for release
into the intestine and so cannot activate intestinal FXR. In this
case, transcriptional suppression of CYP7A1 by FGF15 signalling
would not be expected to occur, which may explain the modest
decrease in expression that we observe in liver from LLKB1KO
mice.
Dramatically elevated levels of circulating non-esterified
cholesterol were observed in the LLKB1KO mice, which is
most likely to be a secondary effect resulting from the reduced
clearance of bile acids. It has been reported that cholestasis
results in the appearance of a specific form of lipoprotein, LP-
X (lipoprotein-X), which has a high content of non-esterified
cholesterol and unusual protein content [36,37]. It is likely that
LP-X makes up a proportion of the elevated LDL observed
in the LLKB1KO mice. An attractive hypothesis is that the
increased circulating free cholesterol leads to the defect in
red blood cells that we observed in the LLKB1KO mice.
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Figure 7 Development of hyperbilirubinaemia in LLKB1KO mice
(A) Semi-thin sections of livers from wild-type (Wt) or LLKB1KO mice showing red blood cells inside blood vessels of 18-day-old mice. An example representative of three livers of mice aged
18–21 days is shown. (B) Osmotic fragility of red blood cells isolated from 15-day-old wild-type and LLKB1KO mice. Relative haemolysis compared with 100 % in pure water (Os = 0) (n = 6). (C)
Haemocrit values of 15-day-old mice (n = 6). rbc, red blood cell. (D) Serum levels of conjugated and unconjugated bilirubin from LLKB1KO mice of different ages (shown in days) (n = 5). Inset
shows the marked yellow appearance of serum from LLKB1KO compared with wild-type mice. Results are means+−S.E.M. Statistically significant differences from the wild-type values are shown by
* (P < 0.05), ** (P < 0.01) and *** (P < 0.001).
Supporting this is a previous study that has shown that high
circulating free cholesterol can alter the composition of the red
blood cell membrane [38]. Excess membrane cholesterol leads
to characteristic morphological abnormalities and formation of
spur cells. The altered lipid composition of the red blood cell
membrane results in spur cells with decreased deformability,
which is essential for passage through capillary beds [39].
Destruction of the spur cells by the spleen ultimately leads to
anaemia, as the bone marrow cannot produce sufficient new cells
to compensate for the loss. The increased destruction of red
blood cells leads to a further increase in circulating bilirubin,
which cannot be appropriately disposed of in the bile due to
defective canaliculi and bile ducts, thereby leading to excessive
accumulation in the serum. It is apparent that the liver is able to
conjugate the majority of the excess bilirubin, which shows the
liver, even in late stages, maintains some functionality and the
hyperbilirubinaemia is probably due to impaired transport and
export from the liver. In a previous study, it has been shown
that radixin deficiency causes conjugated hyperbilirubinaemia
with loss of MRP2 (the major transporter of bilirubin) from
the canalicular membranes [40]. As radixin is depleted in
LLKB1KO mice, this is a possible explanation for elevated levels
of conjugated bilirubin.
In a previous study in which LKB1 expression was deleted
in adult liver [15], there was no report of altered bile acid or
cholesterol metabolism. One possible reason for the absence of
this phenotype could be that LKB1 activity was not completely
abolished in that model, and that this might reduce the severity of
the subsequent phenotype. However, an alternative explanation is
that, in adult livers, biliary tree formation would have progressed
c© The Authors Journal compilation c© 2011 Biochemical Society© 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
2
Role of LKB1 in bile acid transport and canalicular membrane integrity 59
normally through development, precluding the onset of the
phenotype we describe in our model.
The lack of open tubular bile ducts and areas of necrosis in the
postnatal livers observed in livers from LLKB1KO mice are akin
to observations seen in murine models of Alagille syndrome which
are due to alterations in Notch signalling [41,42]. As in Notch2
inactivation, loss of LKB1 activity results in defective intrahepatic
bile duct development. However, to date, there has been no direct
connection made between Notch and LKB1 signalling pathways,
although further investigation may be warranted.
In summary, in the present study we have shown a key role for
LKB1 in co-ordinating the localization of canalicular membrane
proteins and canalicular formation. The lack of LKB1 leads to the
inability of the liver to transport and dispose of constituents of
bile, resulting in a toxic build up of circulating bile acids, bilirubin
and non-esterified cholesterol. It is noteworthy that deletion of
both AMPKα1 and α2 in the liver does not result in a similar
phenotype to the present model [43], but a very recent study
in isolated hepatocytes reported a role for LKB1 and AMPK in
the formation and maintenance of the canalicular network [44].
This finding supports a role for LKB1, AMPK and AMPK-related
kinases in bile acid metabolism and canalicular formation. Further
studies aimed at investigating the role of AMPK and the AMPK-
related kinases downstream of LKB1 in hepatic development and
liver disease is warranted. In summary, our present study uncovers
a new role for LKB1 in the liver adding to the list of diverse
functions of this master regulatory kinase.
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